By contrast, administration of anti-PD-1 drugs increased the number and size of HCC nodules in preclinical models, thereby suggesting a detrimental effect of CD8+ T cells rather than an invigorating effect on immune surveillance in this pathological setting.16 The gene discussed is PDCD1; the disease is hepatocellular carcinoma.